H5N1: The strange tale of Canada’s Ebola vaccine
Via The Star, a column by Thomas Walkom: The strange tale of Canada’s ebola vaccine. Excerpt: The strange case of Canada’s Ebola vaccine became even stranger Monday. That’s when the pharmaceutical multinational Merck announced it will pay $50 million for…
Source: crofsblogs.typepad.com
See on Scoop.it – Virology and Bioinformatics from Virology.ca